News - UF Innovate

UF to Lead National Trial Testing Nerve Block to Alleviate Headache from Subarachnoid Hemorrhage

A multidisciplinary team of neurocritical care, neurosurgery and pain medicine investigators from the University of Florida has been awarded a $12.9 million National Institutes of Health grant to test a novel way to relieve pain from sudden, excruciating headaches stemming from a burst brain aneurysm that causes bleeding.

Amend Surgical Receives Funding for Suture-less Nerve Repair Device

Amend Surgical, Inc., a UF Innovate | Accelerate client, has been awarded substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center to commercialize a novel, suture-less solution for the repair of peripheral nerves. Tissure is a resorbable hydrogel membrane with a chitosan-based adhesive that has the adhesion and mechanical strength to potentially replace sutures for the repair of peripheral nerve injuries.

UF Will Spearhead DARPA Mission To Pioneer Crucial Biomanufacturing in Space

With the goal of creating a resilient supply chain for a sustained presence in space, researchers at the University of Florida (UF) are bioengineering microbes for experimentation on the International Space Station (ISS) they hope will reliably produce biopolymers, nutraceuticals, and antibiotics in variable gravity conditions.

3D-Printing the Brain’s Blood Vessels With Silicone Could Improve and Personalize Neurosurgery – New Technique Shows How

UF Innovate inventor, Thomas Angelini, an associate professor of mechanical and aerospace engineering, and Senthilkumar Duraivel, a Ph.D. candidate in materials science and engineering at UF's Herbert Wertheim College of Engineering, recently published research into a new technique for creating a replica of the brain using 3D printing

UF Researchers Create Method To Predict Leukemia Drug Complications

A team of University of Florida researchers, led by UF Inventor Jatinder Lamba, Ph.D., associate dean of research and graduate education and a professor in the UF College of Pharmacy, made a comprehensive pharmacogenomics evaluation of key genes involved in the pathways of several commonly used drugs to treat acute lymphoblastic leukemia, or ALL, the most common type of leukemia in children.

IdentifySensors Adds Four Regulatory and Quality Experts To Move New Technology to Commercialization

UF Innovate client's, IdentifySensors® Biologics, a leading developer of digital diagnostic technologies, has named four new industry specialists in regulatory, quality and supply chain to oversee good manufacturing and FDA submissions for the company's Check4® digital diagnostics platform product pipeline.

The Transformative Power of Tech Transfer: How One University Makes an Impact Around the Globe

UF Innovate has served as a model for universities nationwide looking to further their tech transfer efforts. UF connects innovators with entrepreneurs, investors and industry experts, while its business incubators (The Hub and Sid Martin Biotech) take research discoveries from the laboratory to the market. Since its inception in 1995, UF Innovate has generated more than $10.4 billion in private investments, launched upwards of 300 startups via tech licensing, and created 7,900-plus startup jobs.

New Scientist Takes Aim at TB, the World’s Deadliest Infectious Disease

Luiz Pedro Carvalho, Ph.D., is on a quest to find new medicines for treatment-resistant diseases, including tuberculosis, which is again the world’s deadliest infectious disease, after briefly falling behind COVID-19. Carvalho is the newest faculty member to join The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology as a professor of chemistry.

UF Health Scientist Lands First-Ever NIH Grant for a Rare Disorder Devastating Lives of Kids

UF Health biochemist and molecular geneticist Andrew Liu, Ph.D., and his collaborators were awarded a $2.4 million, five-year grant in January to investigate the genetic underpinnings of Smith-Kingsmore syndrome, or SKS.

Amend Surgical Unveils Tough Adhesive Hydrogel for Intraoral Adhesion and Drug Delivery

In a groundbreaking development, Amend Surgical has announced the first-ever publication on the use of its Amend Tissue Tape, also known as DenTAI, in an oral application. The company is thrilled to report that the results have exceeded expectations and validated the extensive research and development that has gone into this revolutionary product platform. This exciting news paves the way for Amend Surgical to bring its transformative product to the market next year.

UF News